Home Page of Motility Incorporated Motility Inc targets eye disorders which lead to vision loss and blindness.Motility Inc developed LD22-4 to research it's effectiveness in treating macular degeneration (amd), proliferative vitreoretinopathy (pvr) and malignant gliomas. Motilityinc.com~Site InfoWhoisTrace RouteRBL Check